Quest Diagnostics to Speak at the Baird 2026 Global Healthcare Conference
SECAUCUS, N.J., Aug. 25, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO and President, will speak on the company's strategy, performance and the latest market developments and trends...
Covered in this story
What has happened since
- Quest Diagnostics is down 3.6% since this was published, 56 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Quest Diagnostics
- Truist Securities: $228 → $250 by Jul 2027 · Hold via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $DGX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Quest Diagnostics →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.